Design, Development, Characterization and Testing of CD22 Targeted Long Circulating Liposomal Drug Delivery Systems for B Cell MalignanciesNivesh Mittal(University of Tennessee Health Science Center)UnknownMay 1, 201510.21007/etd.cghs.2015.0214Cited by 0SaveCiteExport RISWatch citationsRelated PapersFormulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies|Pharmaceutics|2018|5